ROR1 and triple-negative breast carcinoma: While ROR1 expression has been described in other tumour entities such as chronic lymphatic leukaemia, triple negative breast cancer and non‐small lung cancer, this is to our knowledge the first study which investigates ROR1 expression in cSCC.